Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 3Phase 1 2Phase NA 1

Status

Recruiting 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Breast Neoplasms 71Carcinoma, Non-Small-Cell Lung 69Multiple Myeloma 55Prostatic Neoplasms 54Colorectal Neoplasms 42Leukemia, Myeloid, Acute 39Neoplasms 38Melanoma 34Lymphoma 33Ovarian Neoplasms 30Lymphoma, Non-Hodgkin 29Lung Neoplasms 28Squamous Cell Carcinoma of Head and Neck 27Sarcoma 27Neoplasm Metastasis 25Carcinoma, Hepatocellular 24Pancreatic Neoplasms 23Endometrial Neoplasms 23Glioma 22Carcinoma, Renal Cell 22Lymphoma, Large B-Cell, Diffuse 21Hodgkin Disease 21Recurrence 20Leukemia, Lymphocytic, Chronic, B-Cell 20Head and Neck Neoplasms 20Urinary Bladder Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Myelodysplastic Syndromes 18Esophageal Neoplasms 17Hematologic Neoplasms 16

Interventions

ribociclib 1Temozolomide 1Injections 1Everolimus 1ACT001 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Diffuse Intrinsic Pontine Glioma × 30 days × Clear all
NCT05843253 2026-05-29

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Nationwide Children's Hospital

Phase 2 Recruiting
120 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

NCT06838676 2026-05-15

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Nationwide Children's Hospital

Phase 2 Recruiting
60 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

NCT07589257 2026-05-15

A Study of VRT106 in Combination With Radiotherapy in Adult Patients With Diffuse Midline Glioma / Diffuse Intrinsic Pontine Glioma

Guangzhou Virotech Pharmaceutical Co., Ltd.

Phase 2 Recruiting
10 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡